LAMA/LABA Combination, Inhalers

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Current Drug Use Criteria New Drug Evaluation
tiotropium Br/olodaterol HCl STIOLTO RESPIMAT MIST INHAL Y    
umeclidinium brm/vilanterol tr ANORO ELLIPTA BLST W/DEV Y    
aclidinium brom/formoterol fum DUAKLIR PRESSAIR AER POW BA N PA Document  
budesonide/glycopyr/formoterol BREZTRI AEROSPHERE HFA AER AD N PA Document  
fluticasone/umeclidin/vilanter TRELEGY ELLIPTA BLST W/DEV N PA Document  
glycopyrrolate/formoterol fum BEVESPI AEROSPHERE HFA AER AD N PA Document